JP2000505789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000505789A5 JP2000505789A5 JP1997526441A JP52644197A JP2000505789A5 JP 2000505789 A5 JP2000505789 A5 JP 2000505789A5 JP 1997526441 A JP1997526441 A JP 1997526441A JP 52644197 A JP52644197 A JP 52644197A JP 2000505789 A5 JP2000505789 A5 JP 2000505789A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19604095.7 | 1996-01-25 | ||
| DE19604095 | 1996-01-25 | ||
| PCT/DE1997/000170 WO1997026862A2 (de) | 1996-01-25 | 1997-01-27 | Verbesserte konzentrierte injektions- und infusionslösungen für die intravasale anwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000505789A JP2000505789A (ja) | 2000-05-16 |
| JP2000505789A5 true JP2000505789A5 (enExample) | 2004-11-11 |
Family
ID=7784538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9526441A Ceased JP2000505789A (ja) | 1996-01-25 | 1997-01-27 | 注射及び輸液用として血管内に使用する改良された濃縮溶液 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6638913B1 (enExample) |
| EP (1) | EP0876140B1 (enExample) |
| JP (1) | JP2000505789A (enExample) |
| KR (1) | KR100505772B1 (enExample) |
| CN (1) | CN1209751A (enExample) |
| AT (1) | ATE251893T1 (enExample) |
| AU (1) | AU2150497A (enExample) |
| BG (1) | BG62913B1 (enExample) |
| BR (1) | BR9707081A (enExample) |
| CA (1) | CA2244209C (enExample) |
| CZ (1) | CZ234898A3 (enExample) |
| DE (2) | DE19703816A1 (enExample) |
| DK (1) | DK0876140T3 (enExample) |
| ES (1) | ES2208884T3 (enExample) |
| HU (1) | HUP9901355A3 (enExample) |
| IL (1) | IL124676A0 (enExample) |
| NO (1) | NO983438L (enExample) |
| PL (1) | PL328199A1 (enExample) |
| PT (1) | PT876140E (enExample) |
| SK (1) | SK101398A3 (enExample) |
| WO (1) | WO1997026862A2 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| DE69828615T2 (de) * | 1997-10-31 | 2005-12-01 | Walter Reed Army Institute Of Research | Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten |
| CN1217918C (zh) | 1998-04-01 | 2005-09-07 | 卡迪欧梅制药公司 | 氨基环己基醚化合物和其用途 |
| US7524879B2 (en) | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| DE60139944D1 (de) | 2000-10-12 | 2009-10-29 | Genentech Inc | Niederviskose konzentrierte proteinformulierungen |
| US8703126B2 (en) | 2000-10-12 | 2014-04-22 | Genentech, Inc. | Reduced-viscosity concentrated protein formulations |
| DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| US20020169112A1 (en) * | 2001-05-08 | 2002-11-14 | Luc Montagnier | Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections |
| DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| DE60305200T2 (de) | 2003-05-02 | 2007-05-10 | Cardiome Pharma Corp. | Aminocyclohexylether-verbindungen und deren verwendung |
| US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
| CA2561819A1 (en) | 2004-04-01 | 2005-12-01 | Cardiome Pharma Corp. | Prodrugs of ion channel modulating compounds and uses thereof |
| WO2005097087A2 (en) | 2004-04-01 | 2005-10-20 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
| JP5583325B2 (ja) | 2004-11-08 | 2014-09-03 | カーディオム ファーマ コーポレイション | イオンチャネル調節化合物の投与レジメ |
| US20060270708A1 (en) * | 2005-05-25 | 2006-11-30 | Navinta Llc | Novel process for preparation of isotonic aqueous injection of ropivacaine |
| EP1897535A1 (en) * | 2006-08-30 | 2008-03-12 | Dirinco AG | Substitution fluid for haemofiltration |
| US20090239894A1 (en) * | 2008-03-20 | 2009-09-24 | Bjorn Schurad | Stabilized aqueous solutions of ergoline compounds |
| PE20120359A1 (es) | 2009-03-06 | 2012-04-13 | Genentech Inc | Formulacion con anticuerpo |
| US9427186B2 (en) * | 2009-12-04 | 2016-08-30 | Endomagnetics Ltd. | Magnetic probe apparatus |
| US10634741B2 (en) * | 2009-12-04 | 2020-04-28 | Endomagnetics Ltd. | Magnetic probe apparatus |
| PT2542257T (pt) | 2010-03-01 | 2017-10-09 | Bayer Healthcare Llc | Anticorpos monoclonais otimizados contra inibidor da via do fator tecidual (tfpi) |
| CN102319258B (zh) * | 2011-08-04 | 2012-10-31 | 山西诺成制药有限公司 | 一种5%葡萄糖置换液及其制备方法 |
| US8613919B1 (en) | 2012-08-31 | 2013-12-24 | Bayer Healthcare, Llc | High concentration antibody and protein formulations |
| US9592297B2 (en) | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
| EP2968560B1 (en) | 2013-03-11 | 2020-04-29 | Endomagnetics Ltd. | Hypoosmotic solutions for lymph node detection |
| US9234877B2 (en) | 2013-03-13 | 2016-01-12 | Endomagnetics Ltd. | Magnetic detector |
| US9239314B2 (en) | 2013-03-13 | 2016-01-19 | Endomagnetics Ltd. | Magnetic detector |
| KR20150134346A (ko) * | 2013-03-27 | 2015-12-01 | 지이 헬스케어 에이에스 | 진단 조성물을 제조하기 위한 방법 및 시약 |
| JP6821665B2 (ja) | 2015-06-04 | 2021-01-27 | エンドマグネティクス リミテッド | 磁気マーカ |
| AU2019254483B2 (en) * | 2018-04-16 | 2025-02-27 | Merck Patent Gmbh | Viscosity reduction of highly concentrated protein formulations |
| CN110327292A (zh) * | 2019-08-11 | 2019-10-15 | 天津乾丰瑞科技有限公司 | 一种盐酸法舒地尔注射制剂及其制备方法 |
| AU2021322623A1 (en) * | 2020-08-03 | 2023-03-02 | Transluminal Systems, Llc | Devices and methods for trans-arterial osmotic embolization of pathological tissue |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754523A (fr) * | 1969-08-06 | 1971-02-08 | Beecham Group Ltd | Vaccins |
| ES8200082A1 (es) * | 1978-07-04 | 1980-12-16 | Nyegaard & Co As | Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina. |
| JPS58500563A (ja) * | 1981-04-27 | 1983-04-14 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド | グルコ−ス、アミノ酸およびインシユリンを含む透析液 |
| CA1264442A (en) * | 1984-06-22 | 1990-01-16 | Richard L. Veech | Electrolyte solutions and in vivo use thereof |
| IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| GB8906130D0 (en) * | 1989-03-17 | 1989-05-04 | Nycomed As | Compositions |
| JPH0341033A (ja) * | 1989-07-07 | 1991-02-21 | Kyowa Hakko Kogyo Co Ltd | 安定なモチリン類含有製剤 |
| DE59007142D1 (de) | 1990-01-18 | 1994-10-20 | Cereria Amos Sgarbi Spa | Grablicht. |
| GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
| DE4135193C1 (enExample) * | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
| IT1256248B (it) * | 1992-12-24 | 1995-11-29 | Bracco Spa | Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x |
| WO1995026331A1 (es) * | 1994-03-25 | 1995-10-05 | Centro Investigacion Justesa Imagen, S.A. | Nuevos dimeros iodados no ionicos como agentes de contraste a los rayos x, metodo para su preparacion y composiciones farmaceuticas que los contienen |
| DE4446694A1 (de) * | 1994-12-09 | 1996-06-13 | Schering Ag | Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung |
-
1997
- 1997-01-27 BR BR9707081A patent/BR9707081A/pt not_active IP Right Cessation
- 1997-01-27 PL PL97328199A patent/PL328199A1/xx unknown
- 1997-01-27 AU AU21504/97A patent/AU2150497A/en not_active Abandoned
- 1997-01-27 ES ES97914098T patent/ES2208884T3/es not_active Expired - Lifetime
- 1997-01-27 DE DE19703816A patent/DE19703816A1/de not_active Withdrawn
- 1997-01-27 DK DK97914098T patent/DK0876140T3/da active
- 1997-01-27 KR KR10-1998-0705697A patent/KR100505772B1/ko not_active Expired - Fee Related
- 1997-01-27 IL IL12467697A patent/IL124676A0/xx unknown
- 1997-01-27 CN CN97191871A patent/CN1209751A/zh active Pending
- 1997-01-27 EP EP97914098A patent/EP0876140B1/de not_active Expired - Lifetime
- 1997-01-27 CZ CZ982348A patent/CZ234898A3/cs unknown
- 1997-01-27 HU HU9901355A patent/HUP9901355A3/hu unknown
- 1997-01-27 SK SK1013-98A patent/SK101398A3/sk unknown
- 1997-01-27 DE DE59710863T patent/DE59710863D1/de not_active Expired - Fee Related
- 1997-01-27 AT AT97914098T patent/ATE251893T1/de not_active IP Right Cessation
- 1997-01-27 JP JP9526441A patent/JP2000505789A/ja not_active Ceased
- 1997-01-27 CA CA002244209A patent/CA2244209C/en not_active Expired - Fee Related
- 1997-01-27 PT PT97914098T patent/PT876140E/pt unknown
- 1997-01-27 WO PCT/DE1997/000170 patent/WO1997026862A2/de not_active Ceased
-
1998
- 1998-07-21 BG BG102644A patent/BG62913B1/bg unknown
- 1998-07-24 NO NO983438A patent/NO983438L/no not_active Application Discontinuation
-
2000
- 2000-02-14 US US09/504,108 patent/US6638913B1/en not_active Expired - Fee Related